Condition: Diabetic Retinopathy · Sponsor: The Filatov Institute of Eye Diseases and Tissue Therapy
To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.
This description comes directly from the study's public registry record.
Andrii MD Korol, PhD · 380936327266 · andrii.r.korol@gmail.com
Olha MD Pohosian · 380932084927 · olha.a.pohosian@gmail.com
Always discuss trial participation with your own doctor first.
| The Filatov Institute of Eye Diseases and Tissue Therapy | Odesa, Ukraine | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06879834